
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation



